Cysteine proteases as digestive enzymes in parasitic helminths

CR Caffrey, L Goupil, KM Rebello… - PLoS neglected …, 2018 - journals.plos.org
We briefly review cysteine proteases (orthologs of mammalian cathepsins B, L, F, and C)
that are expressed in flatworm and nematode parasites. Emphasis is placed on enzyme …

Advances in new target molecules against schistosomiasis: A comprehensive discussion of physiological structure and nutrient intake

P Zhu, K Wu, C Zhang, SS Batool, A Li, Z Yu… - PLoS …, 2023 - journals.plos.org
Schistosomiasis, a severe parasitic disease, is primarily caused by Schistosoma mansoni,
Schistosoma japonicum, or Schistosoma haematobium. Currently, praziquantel is the only …

RNA Interference in Schistosoma mansoni Schistosomula: Selectivity, Sensitivity and Operation for Larger-Scale Screening

S Štefanić, J Dvořák, M Horn, S Braschi… - PLoS neglected …, 2010 - journals.plos.org
Background The possible emergence of resistance to the only available drug for
schistosomiasis spurs drug discovery that has been recently incentivized by the availability …

Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes

R Löser, J Pietzsch - Frontiers in chemistry, 2015 - frontiersin.org
Papain-like cysteine proteases bear an enormous potential as drug discovery targets for
both infectious and systemic human diseases. The considerable progress in this field over …

Chromosome-scale genome of the human blood fluke Schistosoma mekongi and its implications for public health

M Zhou, L Xu, D Xu, W Chen, J Khan, Y Hu… - Infectious Diseases of …, 2023 - Springer
Background Schistosoma mekongi is a human blood fluke causing schistosomiasis that
threatens approximately 1.5 million humans in the world. Nonetheless, the limited available …

Chemotherapy for fighting schistosomiasis: past, present and future

P Mäder, GA Rennar, AMP Ventura… - …, 2018 - Wiley Online Library
Chemotherapy based on repeated doses of praziquantel remains the most effective control
strategy against schistosomiasis, a neglected tropical disease caused by platyhelminths of …

Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni

T Long, RJ Neitz, R Beasley… - PLoS neglected …, 2016 - journals.plos.org
Background Schistosoma flatworm parasites cause schistosomiasis, a chronic and
debilitating disease of poverty in developing countries. Praziquantel is employed for …

Structural basis for inhibition of cathepsin B drug target from the human blood fluke, Schistosoma mansoni

A Jilkova, P Řezáčová, M Lepšík, M Horn… - Journal of Biological …, 2011 - ASBMB
Schistosomiasis caused by a parasitic blood fluke of the genus Schistosoma afflicts over 200
million people worldwide. Schistosoma mansoni cathepsin B1 (SmCB1) is a gut-associated …

Assessment of reference genes at six different developmental stages of Schistosoma mansoni for quantitative RT-PCR

GO Silveira, MS Amaral, HS Coelho, LF Maciel… - Scientific reports, 2021 - nature.com
Reverse-transcription quantitative real-time polymerase chain reaction (RT-qPCR) is the
most used, fast, and reproducible method to confirm large-scale gene expression data. The …

Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis

L Rojo-Arreola, T Long, D Asarnow, BM Suzuki… - PloS one, 2014 - journals.plos.org
The mevalonate pathway is essential in eukaryotes and responsible for a diversity of
fundamental synthetic activities. 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) …